Recent advances in the endoscopic diagnosis and therapy of upper gastrointestinal, small intestinal, and colonic bleeding

Medical Clinics of North America

Volumn 86, Issue 6, 2002, Pages 1319-1356

  Kovacs, Thomas O G ^a,b   Jensen, Dennis M ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; GLYCERYL TRINITRATE; OCTREOTIDE; PROTON PUMP INHIBITOR; SOMATOSTATIN; VASOPRESSIN;

CLINICAL FEATURE; CLINICAL TRIAL; COLONOSCOPY; DRUG EFFICACY; DRUG HALF LIFE; ENDOSCOPIC THERAPY; ENDOSCOPY; GASTROINTESTINAL HEMORRHAGE; HEMOSTASIS; HUMAN; IMAGING; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SCLEROTHERAPY; TREATMENT OUTCOME;

BLOOD VESSELS; COLONIC DISEASES; ESOPHAGEAL AND GASTRIC VARICES; GASTROINTESTINAL HEMORRHAGE; HEMOSTASIS, ENDOSCOPIC; HUMANS; INTESTINE, SMALL; PEPTIC ULCER HEMORRHAGE; SCLEROTHERAPY;

EID: 0036866872     PISSN: 00257125     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-7125(02)00079-2     Document Type: Review

References (110)

1. Waye JD. Intubation and sedation in patients who have emergency upper GI endoscopy for GI bleeding. Gastrointest Endosc 2000;51:768-71.
2. Liebler JM, Benner K, Putnam T, et al. Respiratory complications in critically ill medical patients with acute upper gastrointestinal bleeding. Crit Care Med 1991;19:1152-7.
3. Kovacs TOG, Jensen DM. Endoscopic control of gastroduodenal hemorrhage. Annu Rev Med 1987;38:267-77.
4. Kovacs TOG, Jensen DM. Therapeutic endoscopy for upper gastrointestinal bleeding. In: Taylor MB, Gollan J, Peppercorn MA, et al, editors. Gastrointestinal Emergencies. 2nd Edition. Baltimore: Williams & Williams; 1997. p. 181-8.
5. Griffiths NJ, Neumlan DA, Welsh JH. The visible vessel as an indicator of uncontrolled or recurrent gastrointestinal tract bleeding. N Engl J Med 1979;300:1411-3.
6. Storey DW, Bown SG, Swain CP, et al. Endoscopic prediction of recurrent bleeding in peptic ulcer. N Engl J Med 1981;305:915-6.
7. Jensen DM. The Visible Vessel, Sentinel Clot and Angiomata: When and How to Treat. ASGE Postgraduate Course; 1988. p. 101-9.
8. Johnston JH. The sentinel clot and invisible vessel: Pathpologic anatomy of bleeding peptic ulcer. Gastrointest Endosc 1984;30:313-5.
9. Swain CP, Storey SW, Down SG, et al. Nature of the bleeding vessel in recurrently bleeding ulcers. Gastroenterology 1986;90:595-608.
10. Swain CP. Pathophysiology of bleeding lesions. Gastrointest Endosc 1990;36:S21-2.
11. Consensus statement on therapeutic endoscopy and bleeding ulcers. Gastrointest Endosc 1990;36:S62-5.
12. Fleisher DE. Endoscopic control of upper gastrointestinal bleeding. J Clin Gastroenterol 1990;12:541-7.
13. NIH Consensus Conference. Therapeutic endoscopy and bleeding ulcers. JAMA 1989;262:1369-72.
14. Lau JY, Chung SC, Leung JW, et al. The evolution of hemorrhage in bleeding peptic ulcers: A sequential endoscopic study. Endoscopy 1988;30:513-18.
15. Chung SCS, Leung JWC, Steele RJC, et al. Endoscopic injection of adrenaline for actively bleeding ulcers: A randomized trial. BMJ 1998;296:1631-3.
16. Jensen DM, Kovacs TOG, Juthaba R, et al. Final results and cost assessment of endoscopic vs medical therapies for prevention of recurrent ulcer hemorrhage from adherent clots in a randomized controlled trial [abstract]. Gastrointestinal Endosc 1995;365:279.
17. Swain CP, Salmon PR, Kirkham JS, et al. Controlled trial of Nd-YAG laser photocoagulation in bleeding peptic ulcers. Lancet 1986;1:1113-36.
18. Laine L, Cohen H, Broadhead J, et al. Prospective evaluation of immediate versus delayed rebleeding and prognostic value of endoscopy in patients with upper gastrointestinal hemorrhage. Gastroenterology 1992;102:314-6.
19. Johnston JH, Jensen DM, Auth D. Experimental comparison of endoscopic Yttrium-aluminum-Garnet laser, electrosurgery, and heater probe for canine gut arterial coagulation: The importance of vessel compression and avoidance of tissue erosion. Gastroenterology 1987;92:1101-8.
20. Cipoletta L, Bianco MA, Rotondano G, et al. Prospective comparison of argon plasma coagulator and heater probe in the endoscopic treatment of major peptic ulcer bleeding. Gastrointest Endosc 1998;48:191-95.
21. Frietas D, Donato A, Monteiro JG. Controlled trial of liquid monopolar electro-coagulation in bleeding peptic ulcers. Am J Gastroenterol 1985;80:853-7.
22. Moreto M, Zaballa M, Ibanez S, et al. Efficacy of monopolar electrocoagulation in the treatment of bleeding gastric ulcer: A controlled trial. Endoscopy 1987;19:54-6.
23. Papp JP. Endoscopic electrocoagulation of the non-bleeding visible ulcer vessel [abstract]. Gastrointest Endosc 1979;25:45.
24. Papp JP. Monopolar and electrohydrothermal treatment of upper gastrointestinal bleeding. Gastrointest Endosc 1990;36:S34-7.
25. Wara P, Hogsgaard A, Andrup E. Endoscopic electrocoagulation: An alternative to operative hemostasis in active gastroduodenal bleeding. Endoscopy 1980;12:237-40.
26. Jensen D. Hirabayashi, and CURE Hemostasis Research Group. A study of coagulation depths with BICAP and heater probe to improve endoscopic hemostasis of bleeding peptic ulcers [abstract]. Gastrointest Endosc 1989;35:181.
27. Morris DL, Brearley S, Thompson H, et al. A comparison of the efficacy and depth of gastric wall injury with 3.2 and 2.3 mm bipolar probes in canine arterial hemorrhage. Gastrointest Endosc 1985;31:361-3.
28. Laine L. Determination of the optimal technique for bipolar electrocoagulation treatment: An experimental evaluation of the BICAP and Gold probes. Gastroenterology 1991;100:107-12.
29. Jensen DM, Kovacs TOG, Freeman M, et al. A multicenter randomized prospective study of Gold probe for hemostasis of very severe ulcer or Mallory-Weiss Bleeding [abstract]. Gastroenterology 1991;100(Suppl A):92.
30. Johnston J, Rawson S, Hamihira Y. Experimental comparison of heater probe and BICAP for endoscopic treatment of gastrointestinal bleeding [abstract]. Gastrointest Endosc 1985;31:15.
31. Jensen DM. Heat probe for hemostasis of bleeding peptic ulcers: Techniques and results of randomized controlled trials. Gastrointest Endosc 1990;36:S42-9.
32. Randall GA, Jensen DM, Hirabayashi K, et al. Controlled study of different sclerosing agents for coagulation of canine gut arteries. Gastroenterology 1989;96:1271-81.
33. Lai KM, Peng SN, Guo WS, et al. Endoscopic injection for the treatment of bleeding ulcers: Local tamponade or drug effect? Endoscopy 1994;26:338-41.
34. Sanowski RA, Waring JP. Endoscopic injection therapy for nonvariceal bleeding lesions of the upper gastrointestinal tract [editorial]. J Clin Gastroenterol 1989;11:247-52.
35. Jutabha R, Jensen DM, Machicado GA, et al. Randomized controlled studies of injection gold probe compared with monotherapies for hemostasis of bleeding canine gastric ulcers. Gastrointest Endosc 1998;48:598-605.
36. Chung IK, Ham JS, Kim HS, et al. Comparison of the hemostatic efficacy of the endoscopic hemoclip method with hypertonic saline-epinephrine injection and a combination of the two for the management of bleeding peptic ulcers. Gastrointest Endosc 1999;49:13-8.
37. Chung SCS, Lau JY, Sung JY, et al. Randomized comparison between adrenaline injection and adrenaline injection plus heat probe treatment for actively bleeding ulcers. BMJ 1997;314:1307-11.
38. Jensen DM, Kovacs TOG, Randall G, et al. Prospective study of thermal coagulation (Gold probe) vscombination injection and thermal treatment of high risk patients with severe ulcer or Mallory-Weiss bleeding [abstract]. Gastrointest Endosc 1994;40:25.
39. Jensen DM. Thermal probe or combination therapy for non-variceal UGI hemorrhage. Techniques in Gastrointestinal Endoscopy 1999;1:107-14.
40. Laine L. Multipolar electrocoagulation in the treatment of peptic ulcers with non-bleeding visible vessels. A prospective controlled trial. Ann Intern Med 1989;110:510-4.
41. Cook DJ, Guyatt GH, Salena BJ, et al. Endoscopic therapy for acute non-variceal upper gastrointestinal hemorrhage: A meta-analysis. Gastroenterology 1992;102:139-48.
42. Jensen DM, Kovacs TOG, Jutabha R, et al. Randomized controlled trial of medical therapy compared with endoscopic therapy for prevention of recurrent severe ulcer hemorrhage in patients with non-bleeding adherent clots. Gastrointest Endosc 2000;51:AB140.
43. Jensen DM. Spots and clots - Leave them or treat them? Why and how to treat. Can J Gastroenterol 1999;13:413-5.
44. Bleau BF, Gostout CJ, Shaw MJ, et al. Final results: Rebleeding from peptic ulcers associated with adherent clots: A prospective randomized controlled study comparing endoscopic therapy with medical therapy. Gastrointest Endosc 1997;45:251.
45. Lai KC, Hui WM, Wong BC, et al. A retrospective and prospective study on the safety of discharging selected patients with duodenal ulcer bleeding on the same day as endoscopy. Gastrointest Endosc 1997;45:27-30.
46. Longstreth GF, Feitelberg SP. Successful outpatient management of acute upper gastrointestinal hemorrhage: Use of practice guidelines in a large patient series. Gastrointest Endosc 1998;47:219-22.
47. Rutgeerts P, Rawds E, Wara P, et al. Randomized trial of single and repeated fibrin glue compared with injection of polidocanol in the treatment of bleeding peptic ulcer. Lancet 1997;350:692-6.
48. Saeed Z, Cole RA, Ramirez FC, et al. Endoscopic retreatment after successful initial hemostasis prevents ulcer rebleeding: A prospective randomized trial. Endoscopy 1996;28:288-94.
49. Messmann H, Schaller P, Andus T, et al. Effect of programmed endoscopic follow-up examination on the rebleeding rate of gastric or duodenal peptic ulcers treated by injection therapy: A prospective, randomized controlled trial. Endoscopy 1998;30:583-89.
50. Lau JYW, Sung JJY, Lam YH, et al. Endoscopic retreatment compared with surgery in patients with recurrent bleeding after initial endoscopic control of bleeding ulcers. N Engl J Med 1999;340:751-6.
51. Jensen DM. Management of severe ulcer rebleeding. N Engl J Med 1999;340:799-801.
52. Norton ID, Peterson BT, Sarbi D, et al. Management and long-term prognosis of Dieulafoy's lesion. Gastrointest Endosc 1999;50:762-7.
53. Naroyan S, Jensen DM, Randall GM, et al. Gastric bleeding from Dieulafoy's lesion versus peptic ulcer [abstract]. Gastrointest Endosc 1992;38:239.
54. Laine L. Multipolar electrocoagulation in the treatment of active upper gastrointestinal tract hemorrhage: A prospective controlled trial. N Engl J Med 1987;316:1613-17.
55. Jensen DM, Kovacs TOG, Machicado GA, et al. Prospective study of the stigmata of hemorrhage and endoscopic and medical treatment of bleeding Mallory-Weiss tears. Gastrointest Endosc 1992;38:225.
56. Kovacs TOG, Jensen DM. Endoscopic diagnosis and treatment of bleeding Mallory-Weiss tears. Gastrointest Endosc Clin N Am 1991;1:387-4001991.
57. Machicado GA, Jensen DM, Randall GM. Upper gastrointestinal angiomata - Diagnosis and treatment. Gastrointest Endosc Clin N Am 1991;1:241-62.
58. Savides TJ, Jensen DM, Cohen J, et al. Severe upper gastrointestinal tumor bleeding: Endoscopic findings, treatment, and outcome. Endoscopy 1996;28:244-8.
59. American Gastroenterological Association. Medical position statement: Evaluation and management of occult and obscure gastrointestinal bleeding. Gastroenterology 2000;118:197-200.
60. Antinori CH, Andrew CI, Santaspirit JS, et al. The many faces of aortoenteric fistulas. Am Surg 1996;62:348-49.
61. Garceau AJ, Chalmers TC, the Boston Inter-Hospital Liver Group. The natural history of cirrhosis: I. Survival with esophageal varices. N Engl J Med 1963;268:469-73.
62. The North Italian Endoscopic Club for the Study and Treatment of Esophageal Varices. Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. A prospective multicenter study. N Engl J Med 1988;319:983-9.
63. Graham D, Smith JL. The course of patients after variceal hemorrhage. Gastroenterology 1981;80:800-9.
64. Bosch J. Medical treatment of portal hypertension. Digestion 1998;59:547-55.
65. Chan LY, Sung JJY. Review article: The role of pharmaco-therapy for acute variceal hemorrhage in the era of endoscopic hemostasis. Aliment Pharmacol Ther 1997;11:45-50.
66. Kravetz D, Bosch J, Teres J, et al. Comparison of intravenous somatostatin and vasopressin infusions in treatment of acute variceal hemorrhage. Hepatology 1984;4:442-6.
67. Jenkins SA, Baxter JN, Corbett W, et al. A prospective randomized controlled clinical trial comparing somatostatin and vasopressin in controlling acute variceal hemorrhage. BMJ 1985;290:275-8.
68. Walker S, Kreichgauer HP, Bode JC. Terlipressin versus somatostatin in bleeding esophageal varices: A controlled, double blind study. Hepatology 1992;15:1023-30.
69. Avgerinos A, Klonis C, Rekoumis G, et al. A prospective randomized trial comparing somatostatin, balloon tamponade and the combination of both methods in the management of acute variceal hemorrhage. J Hepatol 1991;13:78-83.
70. Jaramillo JL, de la Mata M, Mino G, et al. Somatostatin versus Sengstaken balloon tamponade for primary hemostasis of bleeding esophageal varices: A randomized pilot study. J Hepatol 1991;12:100-5.
71. Hanas R, Quer JC, Boix J, et al. A prospective randomized trial comparing somatostatin and sclerotherapy in the treatment of acute variceal bleeding. Hepatology 1994;20:370-5.
72. Shields R, Jenkins SA, Baxter JN, et al. A prospective randomized controlled trial comparing the efficacy of somatostatin with injection sclerotherapy in the control of bleeding esophageal varices. J Hepatol 1992;15:128-37.
73. Sung JJY, Chung SCS, Lai CW, et al. Octreotide infusion or emergency sclerotherapy for variceal hemorrhage. Lancet 1993;342:637-41.
74. D'Amico G, Pagliaro L, Bosch J. The treatment of portal hypertension: A meta-analytic review. Hepatology 1995;22:332-54.
75. Junquera F, Lopez-Talavera JC, Mearin F, et al. Somatostatin plus isosorbide-5-mononitrate versus somatostatin in the control of acute gastroesophageal variceal bleeding: A double blind, randomized, placebo-controlled clinical trial. Gut 2000;46:127-32.
76. Tarnasky PR, Kovacs TOG, Leung F, et al. Octreotide decreases gastric mucosal blood flow: A controlled assessment by endoscopic reflectance spectrophotometry. Gastrointest Endosc 1994;40:56-61.
77. Hwang SJ, Lin HC, Chang CF, et al. A randomized controlled trial comparing octreotide and vasopressin in the control of acute esophageal variceal bleeding. J Hepatol 1992;16:320-5.
78. McKee R. A study of octreotide in esophageal varices. Digestion 1990;45:60-5.
79. Jenkins SA, Shields R, Davies M, et al. A multicenter randomized trial comparing octreotide and injection sclerotherapy in the management and outcome of acute variceal hemorrhage. Gut 1997;41:526-33.
80. Primignani M, Andreoni B, Carpinelli L, et al. Sclerotherapy plus octreotide versus sclerotherapy alone in the prevention of early rebleeding from esophageal varices: A randomized double-blind placebo-controlled multicenter trial. Hepatology 1995;21:1322-7.
81. Besson I, Ingrand P, Person B, et al. Sclerotherapy with or without octreotide for acute variceal bleeding. N Engl J Med 1995;333:555-60.
82. Sung JJ, Chung SC, Yung MY. Prospective randomized study of effects of octreotide on rebleeding from esophageal varices after endoscopic ligation. Lancet 1995;346:1666-9.
83. Kovacs TOG, Jensen DM. Endoscopic treatment of acute esophageal variceal bleeding. Drugs of Today 2000;36:1-15.
84. Jutabha R, Jensen DM, Kovacs TOG. A prospective study of the causes and outcomes of severe UGI hemorrhage in cirrhotics. Gastrointest Endosc 1999;49:AB167.
85. Hartigan PM, Gebhard RL, Gregory PB, et al. Sclerotherapy for actively bleeding esophageal varices in male patients with cirrhosis. Gastrointest Endosc 1997;46:1-7.
86. Baroncini D, Milandri G, Borioni D, et al. A prospective randomized trial of sclero-therapy versus ligation in the elective treatment of bleeding esophageal varices. Endoscopy 1997;29:235-40.
87. Gimson AES, Ramage JK, Panos MZ, et al. Randomized trial of variceal banding ligation versus injection sclerotherapy for bleeding esophageal varices. Lancet 1993;342:391-4.
88. Gralnek IM, Jensen DM, Kovacs TOG, et al. The economic impact of variceal hemorrhage. Cost-effectiveness implications of endoscopic therapy. Hepatology 1999;29:44-50.
89. Hou MC, Liu HC, Kuo BIT, et al. Comparison of endoscopic variceal injection sclerotherapy and ligation for the treatment of esophageal variceal hemorrhage: A prospective randomized trial. Hepatology 1995;21:1517-22.
90. Laine L, El-Newihi HM, Migikovsky B, et al. Endoscopic ligation compared with sclerotherapy for the treatment of bleeding esophageal varices. Ann Intern Med 1993;119:1-7.
91. Lo GH, Lai KH, Cheng JS, et al. A prospective randomized trial of sclerotherapy versus ligation in the management of bleeding esophageal varices. Hepatology 1995;22:466-71.
92. Stiegmann GV, Goff JS, Michaletz-Onody PA, et al. Endoscopic sclerotherapy as compared with endoscopic ligation for bleeding esophageal varices. N Engl J Med 1992;326:1527-32.
93. Laine L, Cook D. Endoscopic ligation compared with sclerotherapy for treatment of esophageal variceal bleeding: A meta-analysis. Ann Intern Med 1995;123:280-7.
94. Jensen DM, Jutabha R, Kovacs TOG, et al. Final results of a randomized prospective study of combination banding and sclerotherapy versus sclerotherapy alone for severe esophageal variceal hemorrhage [abstract]. Gastrointest Endosc 1998;47:50.
95. Gotlib JP. Endoscopic obturation of esophageal and gastric varices with a cyanoacrylic tissue adhesive. Can J Gastroenterol 1990;4:637-8.
96. Jensen DM, Kovacs TOG, Randall GM, et al. A randomized prospective study of emergency sclerotherapy versus banding for bleeding gastric varices: Initial results. [abstract]. Am J Gastroenterol 1993;88:150.
97. Huang YH, Yeh HZ, Chen GH, et al. Endoscopic treatment of bleeding gastric varices by N-butyl-2-cyanoacrylate (Histocryl) injection: Long-term efficacy and safety. Gastrointest Endosc 2000;52:160-7.
98. Grace ND. Diagnosis and treatment of gastrointestinal bleeding secondary to portal hypertension. Am J Gastroenterol 1997;92:1081-91.
99. American Gastroenterological Association. AGA technical review on the evaluation and management of occult and obscure gastrointestinal bleeding. Gastroenterology 2000;118:201-21.
100. Jensen DM, Kovacs TOG, Jutabha R, et al. Gasrointestinal bleeding (GIB) of obscure origin in an era of managed care and push enteroscopy. Gastrointest Endosc 1997;45:AB92.
101. Lewis BS, De Lillo AR, Legnani PE, et al. Primary exploratory laparoscopy in younger patients with obscure gastrointestinal bleeding: A prospective evaluation. Gastrointest Endosc 2001;53:AB114.
102. Iddan G, Meron G, Glukhovsky A, et al. Wireless capsule endoscopy. Nature 2000;405:417.
103. Lewis BS, Swain P. Capsule endoscopy in the evaluation of patients with suspected small intestinal bleeding: The results of the first clinical trial. Gastrointest Endosc 2001;53:AB70.
104. Rossini FP, Pennazio M, Santui R, et al. Early experience with wireless capsule diagnostic endoscopy in patients with small bowel bleeding. Am J Gastroenterol 2000;96:S111-2.
105. Longstreth GF. Epidemiology and outcome of patients hospitalized with acute lower gastrointestinal hemorrhage: A population-based study. Am J Gastroenterol 1997;92:419-24.
106. Jensen DM, Machicado GA. Diagnosis and treatment of severe hematochezia: The role of urgent colonoscopy after purge. Gastroenterology 1988;95:1569-74.
107. Jensen DM, Machicado GA, Jutabha R, and Kovacs TOG. Urgent colonoscopy for the diagnosis and treatment of severe diverticular hemorrhage. N Engl J Med 2000;342:78-82.
108. Jensen DM, Tapia JI, Machicado GA, et al. Hydrothermal probe, hot biopsy forceps and YAG laser for hemostasis in the canine colon. Gastrointest Endosc 1983;29:189.
109. Jensen DM. Endoscopic hemostasis and tumor palliation - Results and techniques. In: Jensen DM, Brunetaud JM, editors. Medical Laser Endoscopy. Dordrecht (The Netherlands): Kluwer Academic Publishers; 1990. p. 45-70.
110. Jensen DM, Machicado GA. Colonoscopy for diagnosis and treatment of severe lower gastrointestinal bleeding: Routine outcomes and cost analysis. Gastrointestinal Endocopy Clinics of North America 1997;7:477-98.